Health and Healthcare
Biotech Busine$$ Daily (APPY, LIFC, KCI, MNOV, MCU)
Published:
AspenBio Pharma (NASDAQ: APPY) entered into a definitive agreement with Novartis Animal Health for AspenBio’s recombinant single-chain bovine products for animals. Shares are up 4% to $6.24.
LifeCell (NASDAQ: LIFC)is to be bought by Kinetic Concepts (NYSE: KCI) for $1.7 billion in cash. The offer is for $51 per share and will allow Kinetic to access the rapidly expanding biosurgery market. Shares of LifeCell are up almost 17% to $50.44 on a 52-week range of $24.53 to $48.28. Kinetic is up almost 6% to $49.79 on a 52-week range of $40.90 to $66.77.
MediciNova (NASDAQ: MNOV) released clinical results on two-year Phase II study of MN-166 on multiple sclerosis. The study showed positive results however the market is not reacting accordingly. Shares are down $0.19, 5%, to $3.81 on a 52-week range of $3.27 to $10.71.
Medicure (AMEX: MCU) continuing to rise on positive results on Aggresat, a tirofiban, released last week. The results show that use of the treatment significantly improved heart attack survival. Today, shares are up over 17% to $0.10 on a 52-week range of $0.05 to $1.64.
Rachel Lopez
April 7, 2008
Take the quiz below to get matched with a financial advisor today.
Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.
Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the
advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future
Take the retirement quiz right here.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.